MedTrace Logo

Single Dose of Clonazepam Versus Intermiittent Diazepam for Febrile Seizures Prevention

NCT04364321 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2021-08-30

No results posted yet for this study

Summary

To study the efficacy and safety of single dose clonazepam compared with intermittent oral diazepam for prevention of recurrent febrile seizures in children who had three or more febrile seizures.

Conditions

  • Recurrent Febrile Convulsion

Interventions

DRUG

Clonazepam 0.5 MG

Clonazepam 0.02 mg/kg only one dose

DRUG

Diazepam Tablets

Diazepam 0.3 mg/kg every 8 hours for 3 doses. (24 hr)

Sponsors & Collaborators

  • Queen Sirikit National Institute of Child Health

    lead OTHER_GOV

Principal Investigators

  • Jinjutha Nithiuthai, MD · Queen Sirikit National Institute of Child Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
60 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-13
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04364321 on ClinicalTrials.gov